Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Archives of Neurology|February 29, 2012
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritisKevin Rostasy, Simone Mader, Kathrin Schanda, et al.
Therapeutic Advances in Neurological Disorders|July 22, 2025
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGADPatrick Schindler, Ulrike Grittner, Rebekka Rust, et al.
Brain Communications|April 5, 2024
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?Kathrin Schanda, Sara Mariotto, Dagmar Rudzki, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Acta Neuropathologica Communications|December 26, 2013
T cell-activation in neuromyelitis optica lesions plays a role in their formationMaria Pohl, Naoto Kawakami, Maja Kitic, et al.
Journal of Neuroinflammation|October 27, 2017
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelinationPatrick Peschl, Kathrin Schanda, Bleranda Zeka, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Multiple Sclerosis and Related Disorders|August 7, 2022
MR imaging in children with transverse myelitis and acquired demyelinating syndromesInes El Naggar, Robert Cleaveland, Eva-Maria Wendel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseRomana Höftberger, María Sepulveda, Thaís Armangue, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Archives of Neurology|February 29, 2012
Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritisKevin Rostasy, Simone Mader, Kathrin Schanda, et al.
Therapeutic Advances in Neurological Disorders|July 22, 2025
Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGADPatrick Schindler, Ulrike Grittner, Rebekka Rust, et al.
Brain Communications|April 5, 2024
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?Kathrin Schanda, Sara Mariotto, Dagmar Rudzki, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Acta Neuropathologica Communications|December 26, 2013
T cell-activation in neuromyelitis optica lesions plays a role in their formationMaria Pohl, Naoto Kawakami, Maja Kitic, et al.
Journal of Neuroinflammation|October 27, 2017
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelinationPatrick Peschl, Kathrin Schanda, Bleranda Zeka, et al.
Journal of Neuroimmunology|May 23, 2020
Diagnostic features of initial demyelinating events associated with serum MOG-IgGRiccardo Orlandi, Sara Mariotto, Sergio Ferrari, et al.
Multiple Sclerosis and Related Disorders|August 7, 2022
MR imaging in children with transverse myelitis and acquired demyelinating syndromesInes El Naggar, Robert Cleaveland, Eva-Maria Wendel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseRomana Höftberger, María Sepulveda, Thaís Armangue, et al.
Pageof 25